Chelation therapy is an intravenous treatment using a solution containing minerals, vitamins, and a special amino acid called EDTA. Researchers feel chelation therapy improves circulation, enabling more oxygen to reach the cells. EDTA is a strong amino acid, and has a strong attrion for heavy metals such as lead, cadmium, nickel, and arsenic. It then binds to the heavy metals and is excreted through the urine. Chelation is usually administered intravenously each week for 20-40 treatments. The infusion lasts for 1 ½ – 3 hours, depending on the dose.
According to research heavy metals may, increase oxidative stress, promote inflammation, interfere with calcium signaling, affect endothelial function, increase blood pressure levels, and induce renal function. According to the Trial To Access Chelation Therapy there is extensive epidemiological evidence that metal pollutants are associated with cardiovascular disease. There is some evidence that this association is strengthened in patients with diabetes.
*Chelation therapy is considered an alternative treatment, and has not been approved by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease.